Tasly Pharmaceutical Group Co Ltd Free Cash Flow Generation Index
Tasly Pharmaceutical Group Co Ltd free cash flow generation index. Tasly Pharmaceutical Group Co Ltd (600535) has a Free Cash Flow Generation Index of 0.79x as of December 2025. Free cash flow of CN¥434.36 Million represents 1% of operating cash flow (CN¥552.13 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Tasly Pharmaceutical Group Co Ltd (2001–2025)
Free cash flow generation index of Tasly Pharmaceutical Group Co Ltd from 2001 to 2025. Historical FCF Generation Index trend for Tasly Pharmaceutical Group Co Ltd across 24 annual periods. See how financially flexible is Tasly Pharmaceutical Group Co Ltd to measure the company's free cash flow as a share of total liabilities.
Tasly Pharmaceutical Group Co Ltd Free Cash Flow Generation Index by Year (2001–2025)
Tasly Pharmaceutical Group Co Ltd free cash flow generation index by year from 2001 to 2025. Year-by-year Free Cash Flow Generation Index for Tasly Pharmaceutical Group Co Ltd. For the full cash flow conversion analysis, see Tasly Pharmaceutical Group Co Ltd (600535) cash flow conversion.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.73x | CN¥1.04 Billion | CN¥1.42 Billion | CN¥381.26 Million | ▲ +1.8% |
| 2024 | 0.72x | CN¥1.45 Billion | CN¥2.01 Billion | CN¥564.94 Million | ▼ -2.8% |
| 2023 | 0.74x | CN¥1.91 Billion | CN¥2.58 Billion | CN¥668.82 Million | ▼ -10.1% |
| 2022 | 0.82x | CN¥1.88 Billion | CN¥2.29 Billion | CN¥403.45 Million | ▲ +3.5% |
| 2021 | 0.80x | CN¥2.23 Billion | CN¥2.80 Billion | CN¥571.73 Million | ▲ +3.1% |
| 2020 | 0.77x | CN¥1.38 Billion | CN¥1.79 Billion | CN¥408.81 Million | ▲ +36.6% |
| 2019 | 0.57x | CN¥949.37 Million | CN¥1.68 Billion | CN¥730.78 Million | ▲ +18.3% |
| 2018 | 0.48x | CN¥713.69 Million | CN¥1.49 Billion | CN¥780.10 Million | ▼ -12.4% |
| 2016 | 0.55x | CN¥629.05 Million | CN¥1.15 Billion | CN¥524.68 Million | ▲ +146.6% |
| 2015 | -1.17x | CN¥-397.84 Million | CN¥340.00 Million | CN¥737.84 Million | ▼ -422.3% |
| 2014 | -0.22x | CN¥-138.17 Million | CN¥616.76 Million | CN¥754.93 Million | ▲ +75.6% |
| 2013 | -0.92x | CN¥-317.39 Million | CN¥346.17 Million | CN¥663.56 Million | ▼ -1727.2% |
| 2012 | 0.06x | CN¥23.29 Million | CN¥413.31 Million | CN¥390.02 Million | ▲ +102.6% |
| 2011 | -2.13x | CN¥-287.44 Million | CN¥135.14 Million | CN¥422.58 Million | ▼ -467.1% |
| 2010 | 0.58x | CN¥228.92 Million | CN¥395.05 Million | CN¥166.13 Million | ▼ -18.2% |
| 2009 | 0.71x | CN¥283.58 Million | CN¥400.39 Million | CN¥116.80 Million | ▲ +26.5% |
| 2008 | 0.56x | CN¥145.69 Million | CN¥260.21 Million | CN¥114.51 Million | ▲ +510.3% |
| 2007 | 0.09x | CN¥20.33 Million | CN¥221.55 Million | CN¥201.23 Million | ▲ +111.2% |
| 2006 | -0.82x | CN¥-114.84 Million | CN¥140.56 Million | CN¥255.41 Million | ▼ -115.6% |
| 2005 | -0.38x | CN¥-81.43 Million | CN¥214.90 Million | CN¥296.33 Million | ▲ +53.7% |
| 2004 | -0.82x | CN¥-166.35 Million | CN¥203.27 Million | CN¥369.62 Million | ▲ +82.1% |
| 2003 | -4.57x | CN¥-269.74 Million | CN¥59.00 Million | CN¥328.74 Million | ▼ -1276.5% |
| 2002 | 0.39x | CN¥80.13 Million | CN¥206.22 Million | CN¥126.09 Million | ▲ +191.5% |
| 2001 | -0.42x | CN¥-35.59 Million | CN¥83.77 Million | CN¥119.35 Million | — |